Weiss Ratings Reaffirms "Sell (E+)" Rating for Aemetis (NASDAQ:AMTX)

Key Points

• Weiss Ratings has reaffirmed a "Sell (E+)" rating for Aemetis (NASDAQ: AMTX), indicating concerns about the company's performance.
• Aemetis reported a loss of ($0.41) EPS for the last quarter, falling short of analyst expectations of ($0.35), with revenues at $52.24 million compared to forecasts of $78.68 million.
• Despite the negative rating from Weiss Ratings, several analysts have issued "Buy" ratings, raising the target price, with a consensus target price of $17.33 for the stock.

Aemetis (NASDAQ:AMTX - Get Free Report)'s stock had its "sell (e+)" rating reissued by equities researchers at Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.

Several other equities analysts have also commented on AMTX. Ascendiant Capital Markets boosted their price target on Aemetis from $20.00 to $21.00 and gave the stock a "buy" rating in a research report on Monday. UBS Group upped their target price on Aemetis from $2.20 to $3.00 and gave the company a "buy" rating in a research report on Monday, June 30th. Three equities research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $17.33.

Aemetis Price Performance

Aemetis stock traded down $0.10 during midday trading on Wednesday, hitting $2.91. 818,484 shares of the company were exchanged, compared to its average volume of 952,642. The company's fifty day moving average price is $2.49 and its 200-day moving average price is $2.18. The company has a market cap of $183.71 million, a PE ratio of -1.79 and a beta of 1.68. Aemetis has a fifty-two week low of $1.22 and a fifty-two week high of $4.73.

Aemetis (NASDAQ:AMTX - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The specialty chemicals company reported ($0.41) EPS for the quarter, missing the consensus estimate of ($0.35) by ($0.06). The company had revenue of $52.24 million during the quarter, compared to analysts' expectations of $78.68 million. On average, analysts expect that Aemetis will post -2.07 EPS for the current fiscal year.

Insiders Place Their Bets

In other Aemetis news, Director Francis P. Barton sold 26,452 shares of the stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $2.53, for a total value of $66,923.56. Following the sale, the director directly owned 208,518 shares of the company's stock, valued at $527,550.54. This trade represents a 11.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 15.90% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Jane Street Group LLC bought a new position in Aemetis during the second quarter valued at about $634,000. Qube Research & Technologies Ltd purchased a new stake in shares of Aemetis during the second quarter valued at $246,000. Goldman Sachs Group Inc. lifted its holdings in shares of Aemetis by 71.9% during the first quarter. Goldman Sachs Group Inc. now owns 218,404 shares of the specialty chemicals company's stock valued at $380,000 after purchasing an additional 91,367 shares during the last quarter. Nuveen LLC purchased a new stake in shares of Aemetis during the first quarter valued at $153,000. Finally, Russell Investments Group Ltd. lifted its holdings in shares of Aemetis by 412.9% during the second quarter. Russell Investments Group Ltd. now owns 80,754 shares of the specialty chemicals company's stock valued at $200,000 after purchasing an additional 65,010 shares during the last quarter. Institutional investors own 27.02% of the company's stock.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.